Literature DB >> 22734905

Phenotypic presentation of the Ser63Del MPZ mutation.

Lindsey J Miller1, Agnes Patzko, Richard A Lewis, Michael E Shy.   

Abstract

Mutations in MPZ cause CMT1B, the second most frequent cause of CMT1. Elegant studies with Ser63del mice suggest that Ser63del MPZ is retained in the ER where it activates the unfolded protein response (UPR) that contributes to the neuropathy. Clinical information about patients with this mutation is limited. We present clinical and electrophysiological data on a large multigenerational family with CMT1B caused by Ser63del MPZ. The patients have a classical CMT1 phenotype that is much less severe than that of patients with Arg98Cys MPZ that also activates the UPR. These results suggest that clinical presentation along cannot predict which MPZ mutations will be retained in the ER and activate the UPR.
© 2012 Peripheral Nerve Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22734905      PMCID: PMC3731745          DOI: 10.1111/j.1529-8027.2012.00398.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  16 in total

1.  Genetic linkage of hereditary motor and sensory neuropathy type I (Charcot-Marie-Tooth disease) to markers of chromosomes 1 and 17.

Authors:  J C Defesche; J E Hoogendijk; M de Visser; O de Visser; P A Bolhuis
Journal:  Neurology       Date:  1990-09       Impact factor: 9.910

2.  Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells.

Authors:  Marie E Egan; Judith Glöckner-Pagel; Catherine Ambrose; Paula A Cahill; Lamiko Pappoe; Naomi Balamuth; Edward Cho; Susan Canny; Carsten A Wagner; John Geibel; Michael J Caplan
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

3.  MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B.

Authors:  Mario A C Saporta; Brian R Shy; Agnes Patzko; Yunhong Bai; Maria Pennuto; Cinzia Ferri; Elisa Tinelli; Paola Saveri; Dan Kirschner; Michelle Crowther; Cherie Southwood; Xingyao Wu; Alexander Gow; M Laura Feltri; Lawrence Wrabetz; Michael E Shy
Journal:  Brain       Date:  2012-06-10       Impact factor: 13.501

4.  Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study.

Authors:  E Nelis; C Van Broeckhoven; P De Jonghe; A Löfgren; A Vandenberghe; P Latour; E Le Guern; A Brice; M L Mostacciuolo; F Schiavon; F Palau; S Bort; M Upadhyaya; M Rocchi; N Archidiacono; P Mandich; E Bellone; K Silander; M L Savontaus; R Navon; H Goldberg-Stern; X Estivill; V Volpini; W Friedl; A Gal
Journal:  Eur J Hum Genet       Date:  1996       Impact factor: 4.246

5.  Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination.

Authors:  L E Warner; M J Hilz; S H Appel; J M Killian; E H Kolodry; G Karpati; S Carpenter; G V Watters; C Wheeler; D Witt; A Bodell; E Nelis; C Van Broeckhoven; J R Lupski
Journal:  Neuron       Date:  1996-09       Impact factor: 17.173

6.  Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot-Marie-Tooth disease type 1B.

Authors:  T Kulkens; P A Bolhuis; R A Wolterman; S Kemp; S te Nijenhuis; L J Valentijn; G W Hensels; F G Jennekens; M de Visser; J E Hoogendijk
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

7.  Mutation of the myelin P0 gene in Charcot-Marie-Tooth neuropathy type 1B.

Authors:  K Hayasaka; G Takada; V V Ionasescu
Journal:  Hum Mol Genet       Date:  1993-09       Impact factor: 6.150

8.  Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene.

Authors:  K Hayasaka; M Himoro; W Sato; G Takada; K Uyemura; N Shimizu; T D Bird; P M Conneally; P F Chance
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

9.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

10.  Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease.

Authors:  A A Gabreëls-Festen; J E Hoogendijk; P H Meijerink; F J Gabreëls; P A Bolhuis; S van Beersum; T Kulkens; E Nelis; F G Jennekens; M de Visser; B G van Engelen; C Van Broeckhoven; E C Mariman
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910

View more
  14 in total

1.  MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B.

Authors:  Mario A C Saporta; Brian R Shy; Agnes Patzko; Yunhong Bai; Maria Pennuto; Cinzia Ferri; Elisa Tinelli; Paola Saveri; Dan Kirschner; Michelle Crowther; Cherie Southwood; Xingyao Wu; Alexander Gow; M Laura Feltri; Lawrence Wrabetz; Michael E Shy
Journal:  Brain       Date:  2012-06-10       Impact factor: 13.501

2.  Ablation of Perk in Schwann Cells Improves Myelination in the S63del Charcot-Marie-Tooth 1B Mouse.

Authors:  Mariapaola Sidoli; Nicolò Musner; Nicholas Silvestri; Daniela Ungaro; Maurizio D'Antonio; Douglas R Cavener; M Laura Feltri; Lawrence Wrabetz
Journal:  J Neurosci       Date:  2016-11-02       Impact factor: 6.167

Review 3.  Mechanisms and Treatments in Demyelinating CMT.

Authors:  Vera Fridman; Mario A Saporta
Journal:  Neurotherapeutics       Date:  2021-11-08       Impact factor: 6.088

4.  Enhanced axonal neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot-Marie-Tooth type 1B mouse model.

Authors:  Cristina Scapin; Cinzia Ferri; Emanuela Pettinato; Desiree Zambroni; Francesca Bianchi; Ubaldo Del Carro; Sophie Belin; Donatella Caruso; Nico Mitro; Marta Pellegatta; Carla Taveggia; Markus H Schwab; Klaus-Armin Nave; M Laura Feltri; Lawrence Wrabetz; Maurizio D'Antonio
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

5.  Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice.

Authors:  Agnes Patzkó; Yunhong Bai; Mario A Saporta; István Katona; Xingyao Wu; Domenica Vizzuso; M Laura Feltri; Suola Wang; Lisa M Dillon; John Kamholz; Daniel Kirschner; Fazlul H Sarkar; Lawrence Wrabetz; Michael E Shy
Journal:  Brain       Date:  2012-12       Impact factor: 13.501

6.  Impairment of protein degradation and proteasome function in hereditary neuropathies.

Authors:  Jordan J S VerPlank; Sudarsanareddy Lokireddy; M Laura Feltri; Alfred L Goldberg; Lawrence Wrabetz
Journal:  Glia       Date:  2017-10-27       Impact factor: 7.452

7.  Phosphorylation of eIF2α Promotes Schwann Cell Differentiation and Myelination in CMT1B Mice with Activated UPR.

Authors:  Cristina Scapin; Cinzia Ferri; Emanuela Pettinato; Francesca Bianchi; Ubaldo Del Carro; M Laura Feltri; Randal J Kaufman; Lawrence Wrabetz; Maurizio D'Antonio
Journal:  J Neurosci       Date:  2020-09-24       Impact factor: 6.167

8.  Sustained Expression of Negative Regulators of Myelination Protects Schwann Cells from Dysmyelination in a Charcot-Marie-Tooth 1B Mouse Model.

Authors:  Francesca Florio; Cinzia Ferri; Cristina Scapin; M Laura Feltri; Lawrence Wrabetz; Maurizio D'Antonio
Journal:  J Neurosci       Date:  2018-04-02       Impact factor: 6.167

9.  Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice.

Authors:  Maurizio D'Antonio; Nicolò Musner; Cristina Scapin; Daniela Ungaro; Ubaldo Del Carro; David Ron; M Laura Feltri; Lawrence Wrabetz
Journal:  J Exp Med       Date:  2013-04-01       Impact factor: 14.307

10.  Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene.

Authors:  Oranee Sanmaneechai; Shawna Feely; Steven S Scherer; David N Herrmann; Joshua Burns; Francesco Muntoni; Jun Li; Carly E Siskind; John W Day; Matilde Laura; Charlotte J Sumner; Thomas E Lloyd; Sindhu Ramchandren; Rosemary R Shy; Tiffany Grider; Chelsea Bacon; Richard S Finkel; Sabrina W Yum; Isabella Moroni; Giuseppe Piscosquito; Davide Pareyson; Mary M Reilly; Michael E Shy
Journal:  Brain       Date:  2015-08-25       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.